TITLE

New research aims to assess Redux/phen-fen controversy

AUTHOR(S)
Shaw, Kendall
PUB. DATE
December 1998
SOURCE
Drug Store News;12/14/98, Vol. 20 Issue 20, pCP23
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the results of a study on the physiological effects of Redux or phentermine-fenfluramine intake. Average duration of Redux therapy; Rates of mild or greater aortic regurgitation; Mitral valve regurgitation; Cardiovascular symptoms; Aortic regurgitation.
ACCESSION #
1395019

 

Related Articles

  • Diet pills--out with the old, in with the new.  // Consumers' Research Magazine;Nov97, Vol. 80 Issue 11, p40 

    Introduces the fenfluramine and phentermine diet drugs for weight loss endorsed by Eli Lily and Dupont Merck. Advantages of the drug.

  • The demise of diet pills. Napier, Kristine // Prevention;Dec97, Vol. 49 Issue 12, p40 

    Looks at the demise of diet pills as of November 1997. The reported cases of rare heart-valve disease in women who took the weight-loss combo fen-phen (fenfluramine and phentermine) in July 1997; The side effects of Redux; The voluntary removal of both drugs from the market in September 1997...

  • Pulmonary Hypertension Associated with Use of Phentermine. Woo-Dae Bang; Ji-Ye Kim; Hee-Tae Yu; Sung-Soo Cho; Ji-Yong Jang; Chang-Myung Oh; Boyoung Joung; Hyuk-Jae Chang // Yonsei Medical Journal;11/1/2010, Vol. 51 Issue 6, p971 

    Weight-control drugs (known as anorexigens) such as fenfluramine have been linked with pulmonary hypertension in previous reports. In our case, a 29 year old woman was admitted for shortness of breath and was diagnosed with pulmonary hypertension. Three months ago, she had been taking...

  • Fen-phen: Risky for dieters in any form.  // Consumer Reports;Sep97, Vol. 62 Issue 9, p6 

    Reports on the dangers of the diet drug fen-phen and its herbal counterpart, Herbal Fen-Phen. Where Herbal Fen-Phen is sold; Why the US Food and Drug Administration recommended against the use of fen-phen; Deaths related to the use of fen-phen.

  • Every New Mexico drugstore sued over phen-fen. Conlan, Michael F. // Drug Topics;12/7/98, Vol. 142 Issue 23, p24 

    Reports on the state lawsuit against 281 community pharmacies in New Mexico filed at the District Court in Santa Fe in 1998. Allegations of the plaintiffs regarding the manufacturers and sellers of fenfluramine-phentermine; Highlights of the case.

  • Phen-fen frenzy. Clive, Teagan // Joe Weider's Muscle & Fitness;Jan97, Vol. 58 Issue 1, p100 

    Focuses on the phentermine-fenfluramine (phen-fen) drug combination for weight loss. Effectiveness of the combination; Side effects; Disagreement between physicians on the drug combination; Background information on the phen-fen saga; Drug's potential for abuse. INSETS: Who gets phen-fen--and...

  • Acute anorectic effect of single and combined drugs in mice using a non-deprivation protocol. Rowland, Neil E.; Lo, Jeannette; Robertson, Kimberly // Psychopharmacology;2001, Vol. 157 Issue 2, p193 

    Rationale: Studies of the effect of anorectic drugs such as fenfluramine in mice have indicated the desirability of using experimental protocols that do not involve deprivation. Objective: We have developed a non-deprivation or “dessert” protocol for use in mice that are maintained...

  • A primer on Fen-Phen litigation: Allegations and defenses. Evans, John T.; Kerner Jr., Robert L. // Defense Counsel Journal;Jul98, Vol. 65 Issue 3, p353 

    Discusses the pharmacology, pathophysiology and legal ramifications pertaining to Fen-Phen, an appetite suppressant. Reported implications; Legal implications; Conclusion.

  • Initial weight loss as a predictor of response to obesity drugs. Dhurandhar, N V; Blank, R C; Schumacher, D; Atkinson, R L // International Journal of Obesity & Related Metabolic Disorders;Dec1999, Vol. 23 Issue 12, p1333 

    BACKGROUND: Initial weight loss has been used as a predictor of long-term response to obesity drugs. Discontinuation of drugs has been recommended if weight loss is not ≥ 1.81 kg (4 Ib) in the first month of treatment. OBJECTIVE: We compared the weight loss response at 6 months of patients...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics